This page shows the latest antitrust investigation news and features for those working in and with pharma, biotech and healthcare.
It is the third pharmaceutical company to admit to criminal charges in the ongoing investigation by the DoJ’s Antitrust Division, after Heritage Pharmaceuticals and Kavod Pharmaceuticals (previously known as Rising ... Sandoz conspired for years with
taking the lead from an earlier antitrust investigation in the country that resulted in the levying of a 182.5m fine.
An EC investigation concluded in June the Danish pharma company had collaborated with several other companies to delay the entry of generic competition for its big-selling antidepressant Celexa/ Cipramil (citalopram).
Antitrust authorities in Italy open investigation into the pharma companies. Antitrust authorities in Italy have opened an investigation into claims Novartis and Roche colluded to restrict the availability of a
Claims companies agreed to delay entry of generic painkiller. Johnson &Johnson and Novartis are the latest pharma companies to face a European Commission investigation into anticompetitive practices, this time for allegedly ... The 'statement of
The European Commission has launched an antitrust investigation to assess if Johnson &Johnson and Novartis' generics division, Sandoz, hindered entry of generic versions of pain drug fentanyl into the Netherlands. ... The European Commission (EC) has
More from news
Approximately 2 fully matching, plus 5 partially matching documents found.
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...